Pfizer Calls For Fees On US Merck Pneumonia Vaccine At Trial
Pfizer kicked off a London trial against Merck Sharp & Dohme on Tuesday by saying the rival pharmaceutical company's proposed pneumonia vaccine infringes its Prevenar 13 patent, meaning the U.S. drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article